M. Kraus & Co trimmed its stake in The Procter & Gamble Company (NYSE:PG – Free Report) by 2.0% during the fourth quarter, according to its most recent 13F filing with the SEC. The institutional investor owned 60,847 shares of the company’s stock after selling 1,229 shares during the period. Procter & Gamble accounts for about 3.1% of M. Kraus & Co’s investment portfolio, making the stock its 9th largest position. M. Kraus & Co’s holdings in Procter & Gamble were worth $10,201,000 as of its most recent filing with the SEC.
Other institutional investors and hedge funds have also recently added to or reduced their stakes in the company. Itau Unibanco Holding S.A. acquired a new stake in shares of Procter & Gamble in the second quarter valued at about $28,000. RPg Family Wealth Advisory LLC bought a new stake in Procter & Gamble during the 3rd quarter valued at approximately $33,000. Quest Partners LLC acquired a new stake in Procter & Gamble in the 2nd quarter valued at approximately $36,000. Costello Asset Management INC increased its position in Procter & Gamble by 2,142.9% in the 3rd quarter. Costello Asset Management INC now owns 314 shares of the company’s stock worth $54,000 after buying an additional 300 shares during the period. Finally, William B. Walkup & Associates Inc. acquired a new position in shares of Procter & Gamble during the second quarter worth approximately $58,000. 65.77% of the stock is currently owned by institutional investors and hedge funds.
Procter & Gamble Price Performance
Shares of PG stock opened at $159.75 on Thursday. The stock’s fifty day moving average is $169.40 and its 200-day moving average is $169.52. The company has a debt-to-equity ratio of 0.50, a quick ratio of 0.55 and a current ratio of 0.75. The stock has a market capitalization of $376.22 billion, a PE ratio of 27.54, a PEG ratio of 3.70 and a beta of 0.45. The Procter & Gamble Company has a 52 week low of $146.28 and a 52 week high of $180.43.
Procter & Gamble Announces Dividend
The business also recently disclosed a quarterly dividend, which will be paid on Tuesday, February 18th. Investors of record on Friday, January 24th will be given a $1.0065 dividend. This represents a $4.03 annualized dividend and a yield of 2.52%. The ex-dividend date is Friday, January 24th. Procter & Gamble’s dividend payout ratio (DPR) is presently 69.31%.
Insiders Place Their Bets
In other Procter & Gamble news, CEO R. Alexandra Keith sold 1,992 shares of the company’s stock in a transaction dated Tuesday, October 22nd. The shares were sold at an average price of $170.00, for a total transaction of $338,640.00. Following the transaction, the chief executive officer now directly owns 13,783 shares in the company, valued at approximately $2,343,110. This represents a 12.63 % decrease in their position. The transaction was disclosed in a document filed with the SEC, which is accessible through this hyperlink. Also, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction that occurred on Thursday, October 24th. The stock was sold at an average price of $168.99, for a total transaction of $2,163,072.00. Following the sale, the insider now owns 11,566 shares of the company’s stock, valued at approximately $1,954,538.34. This represents a 52.53 % decrease in their position. The disclosure for this sale can be found here. In the last quarter, insiders have sold 75,439 shares of company stock valued at $13,317,460. 0.18% of the stock is currently owned by corporate insiders.
Analysts Set New Price Targets
A number of equities analysts recently issued reports on the stock. Evercore ISI boosted their target price on shares of Procter & Gamble from $180.00 to $183.00 and gave the stock an “outperform” rating in a research report on Monday, October 21st. Morgan Stanley upped their price objective on shares of Procter & Gamble from $174.00 to $191.00 and gave the company an “overweight” rating in a research report on Monday, October 21st. Barclays lowered Procter & Gamble from an “overweight” rating to an “equal weight” rating and set a $163.00 price target on the stock. in a research note on Monday, September 30th. Piper Sandler started coverage on Procter & Gamble in a research report on Tuesday, September 24th. They issued a “neutral” rating and a $174.00 price objective for the company. Finally, JPMorgan Chase & Co. boosted their price objective on Procter & Gamble from $179.00 to $186.00 and gave the company an “overweight” rating in a research report on Thursday, September 19th. Eight investment analysts have rated the stock with a hold rating, fourteen have given a buy rating and two have issued a strong buy rating to the stock. Based on data from MarketBeat.com, Procter & Gamble presently has an average rating of “Moderate Buy” and a consensus price target of $179.75.
Check Out Our Latest Report on Procter & Gamble
Procter & Gamble Profile
Procter & Gamble Co engages in the provision of branded consumer packaged goods. It operates through the following segments: Beauty, Grooming, Health Care, Fabric and Home Care, and Baby, Feminine and Family Care. The Beauty segment offers hair, skin, and personal care. The Grooming segment consists of shave care like female and male blades and razors, pre and post shave products, and appliances.
Featured Stories
- Five stocks we like better than Procter & Gamble
- Dividend King Proctor & Gamble Is A Buy On Post-Earnings Weakness
- 4 Social Media Stocks Set to Gain as TikTok Ban Looms
- How to Evaluate a Stock Before BuyingÂ
- How Do Stock Buybacks Affect Shareholders?
- Insider Selling Explained: Can it Inform Your Investing Choices?
- JPMorgan Chase & Co. Stock Can Hit $300 This Year
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.